We design
the Next Gen Bioprinters
for Regenerative Medecine, Oncology and 3D tissue disease models.
NGB™ robotic bioprinting platform
The NGB™ robotic bioprinting platform is modular and flexible, enabling biofabrication of 3D complex tissues made of (stem) cells, cell spheroids and/or bio-inks.
It stands out for its unique capabilities to develop advanced Tissue Engineering applications from basic research to therapeutic applications.
The NGB™ platform is declined in two versions:
What to expect with NGB platform
HIGH PRECISION
BIOPRINTING
Laser-Assisted Bioprinting ensures precise deposition of microdroplets from multiple cell bioinks with high resolution, enabling the creation of intricate, complex 3D tissue constructs.
ROBOTIZATION
& AUTOMATION
NGB™ platform is equipped with a 6-axis robotic arm and a robotic gripper. It can be configured with multiple bioprinting heads, microfluidics devices and an in line microscope to allow for seamless integration into automated workflows.
BIOCOMPATIBILITY
& GMP COMPLIANCE
Integrated into a Class II BSC, the NGB™ platform has been designed to support advanced bio-processes. NGB-C™ model is fully designed for clinical use, adhering to GMP requirements.
Our bioprinters
NGB-RTM
The Next Generation Bioprinter for Research applications
Provides researchers with state-of-the-art bioprinting technologies for Oncology, 3D tissue disease models and translational research.
NGB-CTM
NGB-C™ Bioprinter commercialized for clinical applications
Equips hospitals and clinics with bioprinting solutions for regenerative medecine and on-site clinical use on therapeutic applications, such as implantable tissues.Do you want to know more about NGB platform?